Rhenman & Partners Asset Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-10,778
| Closed | -$272K | – | 101 |
|
|
2019
Q3 | $272K | Hold |
10,778
| – | – | 0.03% | 86 |
|
|
2019
Q2 | $274K | Hold |
10,778
| – | – | 0.03% | 84 |
|
|
2019
Q1 | $458K | Hold |
10,778
| – | – | 0.05% | 79 |
|
|
2018
Q4 | $157K | Sell |
10,778
-1,440
| -12% | -$21K | 0.02% | 89 |
|
|
2018
Q3 | $855K | Hold |
12,218
| – | – | 0.09% | 72 |
|
|
2018
Q2 | $907K | Sell |
12,218
-642
| -5% | -$47.7K | 0.09% | 72 |
|
|
2018
Q1 | $1.22M | Hold |
12,860
| – | – | 0.15% | 73 |
|
|
2017
Q4 | $1.66M | Buy |
+12,860
| New | +$1.66M | 0.22% | 74 |
|
|
2014
Q4 | – | Sell |
-958
| Closed | -$1.44M | – | 95 |
|
|
2014
Q3 | $1.44M | Hold |
958
| – | – | 0.42% | 86 |
|
|
2014
Q2 | $1.31M | Buy |
958
+256
| +36% | +$351K | 0.39% | 78 |
|
|
2014
Q1 | $974K | Buy |
+702
| New | +$974K | 0.29% | 80 |
|